MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
225 hedge funds and large institutions have $8B invested in Mirati Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 68 increasing their positions, 83 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
18% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 83
20% less call options, than puts
Call options by funds: $150M | Put options by funds: $187M
Holders
225
Holding in Top 10
9
Calls
$150M
Puts
$187M
Top Buyers
| 1 | +$110M | |
| 2 | +$83M | |
| 3 | +$80.7M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$71.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$68.9M |
Top Sellers
| 1 | -$139M | |
| 2 | -$112M | |
| 3 | -$57.6M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$42.2M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$37.4M |